According to the Lizhu Pharmaceutical announcement, the National Health Insurance Administration and the Ministry of Human Resources and Social Affairs issued the “National Basic Medical Insurance, Maternity Insurance and Work Injury Insurance Drug Catalogue”. The company included 3 products. Among them, injectable ariprazole microspheres were included for the first time, injectable triprarelin acetate microspheres added new indications, and the injectable iprazole sodium contract was successfully renewed. The company has no products withdrawn from this catalog. Product inclusion will help expand the market and improve drug accessibility, and is expected to have a positive impact on future results. This edition of the catalogue will be implemented on January 1, 2026, and is not expected to have a significant impact on current results.

According to the Lizhu Pharmaceutical announcement, the National Health Insurance Administration and the Ministry of Human Resources and Social Affairs issued the “National Basic Medical Insurance, Maternity Insurance and Work Injury Insurance Drug Catalogue”. The company included 3 products. Among them, injectable ariprazole microspheres were included for the first time, injectable triprarelin acetate microspheres added new indications, and the injectable iprazole sodium contract was successfully renewed. The company has no products withdrawn from this catalog. Product inclusion will help expand the market and improve drug accessibility, and is expected to have a positive impact on future results. This edition of the catalogue will be implemented on January 1, 2026, and is not expected to have a significant impact on current results.